Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
February 06 2024 - 4:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement |
| ☐ |
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2)) |
| ☐ |
Definitive Proxy Statement |
| ☒ |
Definitive Additional Materials |
| ☐ |
Soliciting Material under §240.14a-12 |
NexImmune, Inc.
(Name
of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☐ |
Fee paid previously with preliminary materials |
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11 |
9119 Gaither Road
Gaithersburg, MD 20877
February 6, 2024
NOTICE
OF POSTPONEMENT OF
SPECIAL MEETING OF STOCKHOLDERS
As disclosed in a Form 8-K filed by NexImmune, Inc. (the “Company”) on February 5, 2024, the Board of
Directors of the Company has determined to postpone the Company’s Special Meeting of Stockholders for the purpose of approving the liquidation and dissolution of the Company and the Plan of Liquidation and Dissolution (the “Special
Meeting”), which was previously scheduled to reconvene on Wednesday, February 7, 2024 at 10:00 a.m., Eastern Time in a virtual format, while continuing to pursue alternatives intended to maximize the value of the business and its assets.
Subject to the outcome of the Company’s pursuit of alternatives to maximize the value of the business and its assets, the Company may call a new Special Meeting of the stockholders to seek approval of the plan of dissolution, set a new record
date for the determination of stockholders of the Company entitled to vote at the postponed Special Meeting, and file proxy materials relating to the postponed Special Meeting with the Securities and Exchange Commission. The new proxy materials and
proxy card would be distributed to the stockholders by the Company in advance of the new meeting date.
NexImmune (NASDAQ:NEXI)
Historical Stock Chart
From Apr 2024 to May 2024
NexImmune (NASDAQ:NEXI)
Historical Stock Chart
From May 2023 to May 2024
